Chronic Adenotonzillitis (HAT) is a determinate disease that externally manifests itself as a permanent infectious-allergic process of the palatine and pharyngeal tonsils in children. As a rule, after a puberty period, this disease transforms into chronic tonsillopharyngitis and is characterized by a post-nasal drip syndrome (drip syndrome)                                                                                   

According to statistics from the Ministry of Health of Ukraine from 2011 to 2016. HAT diseases in children amounted to 47 cases per 10 thousand children (the absolute number of patients is 374 321 people) (Gavrilenko Yu.V. 2016). According to American authors (Shulman STet.al.2012), the primary detection of Dr. hr. tonsillopharigitis in adults amounted to more than 15 million people, which is 2 times higher than the number of patients with other infectious diseases (Kosakovsky A.L. 2015)                                                                 

Clinical studies show that HAT and tonsillopharyngitis (TF) are widespread among the population in all age groups, however, according to> studies, this pathology (HAT) is most often diagnosed in childhood. According to statistics: the annual incidence of TF in the adult population was 1324-1348 cases per 10 thousand people and from 2000 to 3065 cases of CHD per 10 thousand children. (Kosakovsky A.L. 2016)                                   

Modern studies have proved the immunocompetent role of lymphoid tissue of the pharyngeal and palatine tonsils in children. Therefore, the preservation of these organs in a child is a priority for otolaryngologists and pediatricians (Laiko A.A. 2008-13, Melnikov O.F., Zabolotnaya D.D. 2012-13).

Given the fact that HAT is a genetically determined disease, at present, HAT treatment can only be considered as an etiotropic therapy of the infectious component of this pathological process. However, only systemic antibiotic therapy with HAT is ineffective and contributes to the development of resistance of the resident microflora of the tonsils to the antibiotics used. Therefore, one of the fragments of the complex therapy of HAT is the reduction of infectious expression in the parenchyma of the pharyngeal and palatine tonsils and the restoration of the drainage function of the lacunar canals of the palatine tonsils. According to Ukrainian scientists (Kosakovsky A.L. 2015 and Gavrilenko Yu.V. 2016), the most effective way to restore drainage function and rehabilitate n. tonsils is the washing of lacunar channels with antiseptic solutions and the use of topical antiseptics in the form of oral sprays: Tantum Verde (A. Kosakovsky) and Betadin (Yu.V. Gavrilenko) Physiotherapeutic effects are also often used – the effect of drugs on the submandibular region (Electrophoresis, phonophoresis). Unfortunately, all of the named topical antiseptics and drugs targeting the tonsils parenchyma have very short and limited contact with the tissues affected by the pathological process (mucous and tonsil parenchyma). This drawback reduces the therapeutic and clinical effect of targeted therapy of the drugs used. The use of drug electrophoresis on the submandibular region, with the aim of the effect of drugs on the parenchyma of the tonsils, has no therapeutic effect, because there is no direct, direct contact (interaction) of the molecules of the drug substance and tissues of the tonsils. Given this factor, the Halsey Tonzills Clinic has developed a technique for endopharyngeal electrophoresis and a device for its implementation.

Therefore, given this clinical circumstance, it is more advisable to use targeted therapy with the use of drugs with prolonged action (24 hours and>) to treat HAT; which have high adhesive properties, as well as bactericidal effect on the resident tonsils bacflora. As a result of the treatment (during the period of exacerbation of HAT), with drugs with the indicated properties, a pronounced therapeutic effect is achieved, which is confirmed by clinical and laboratory studies: improving the well-being of patients, normalizing UAC, as well as reducing CFU in the tank sowing from the tonsils and nasopharynx. Currently, on the basis of the Helsi-Tonsills ENT center, a phytobalm has been developed and is being successfully applied, which is introduced into the lacunar channels of the NM and nasopharynx and having a high adhesive coefficient, directly penetrates deep into the tonsil parenchyma, providing bactericidal and therapeutic effects for a long time (up to 12 hours or more); thereby contributing to the achievement of maximum therapeutic effect when conducting targeted therapy in the treatment of HAT.

 To perform these treatment procedures, the Halsey Tonsills ENT Center has developed and patented special tools:

1) Disposable Cannula – for the introduction of phytobalm into the lacunar canals of the n.

2) Disposable Probe Massager – for pharyngeal tonsil massage.

Phytobalm and this set of tools help the ENT doctor to perform all medical procedures in the oropharynx – quickly and efficiently, with minimal trauma to the mucous membrane of the palatine and pharyngeal tonsils. To perform endopharyngeal electrophoresis, a special device has been developed and patented.